Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000;157(4):1055–62. https://doi.org/10.1016/S0002-9440(10)64619-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol. 2012;125(2):292–6. https://doi.org/10.1016/j.ygyno.2012.01.034.

Article  PubMed  Google Scholar 

Gallion HH, Van Nagell JR, Donaldson ES, Hanson MB, Powell DE, Maruyama Y, Yoneda J. Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer. 1985;56(2):262–5. https://doi.org/10.1002/1097-0142(19850715)56:2%3c262.

Article  CAS  PubMed  Google Scholar 

Jung EJ, Byun JM, Kim YN, et al. Cervical adenocarcinoma has a poorer prognosis and a higher propensity for distant recurrence than squamous cell carcinoma. Int J Gynecol Cancer. 2017;27(6):1228–36. https://doi.org/10.1097/igc.0000000000001009.

Article  PubMed  Google Scholar 

Yokoi E, Mabuchi S, Takahashi R, et al. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. J Gynecol Oncol. 2017;28(2): e19. https://doi.org/10.3802/jgo.2017.28.e19.

Article  PubMed  Google Scholar 

Rose PG, Java JJ, Whitney CW, Stehman FB, Lanciano R, Thomas GM. Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation. Gynecol Oncol. 2014;135(2):208–12. https://doi.org/10.1016/j.ygyno.2014.08.018.

Article  PubMed  PubMed Central  Google Scholar 

Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer. 1990;65(11):2507–14. https://doi.org/10.1002/1097-0142(19900601)65:11%3c2507.

Article  CAS  PubMed  Google Scholar 

Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003;89(3):343–53. https://doi.org/10.1016/s0090-8258(03)00173-2.

Article  PubMed  Google Scholar 

Eitan R, Levavi H, Peled Y, Brenner R, Sabah G, Ben-Arie A, Dgani R, Fishman A, Sulkes A, Fenig E, Koren C. Should simple hysterectomy be added after chemo-radiation for stage IB2 and bulky IIA cervical carcinoma? Aust N Z J Obstet Gynaecol. 2010;50(3):289–93. https://doi.org/10.1111/j.1479-828X.2010.01164.x.

Article  PubMed  Google Scholar 

van Kol K, Ebisch R, Piek J, Beugeling M, Vergeldt T, Bekkers R. Adjuvant hysterectomy for cervical cancer patients treated with chemoradiation therapy: a systematic review on the pathology-proven residual disease rate. Cancers Basel. 2021;13(24):6190. https://doi.org/10.3390/cancers13246190.

Article  PubMed  PubMed Central  Google Scholar 

Voinea S, Herghelegiu CG, Sandru A, et al. Impact of histological subtype on the response to chemoradiation in locally advanced cervical cancer and the possible role of surgery. Exp Ther Med. 2021;21(1):93. https://doi.org/10.3892/etm.2020.9525.

Article  CAS  PubMed  Google Scholar 

Decker MA, Burke JJ, Gallup DG, Silverio R, Weems DH, Duttenhaver JR, Purcell D. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates. Am J Obstet Gynecol. 2004;191:654–8.

Article  PubMed  Google Scholar 

Chereau E, de la Hosseraye C, Ballester M, et al. The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer. Anticancer Res. 2013;33(4):1661–6.

CAS  PubMed  Google Scholar 

Azria E, Morice P, Haie-Meder C, et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol. 2005;12:332–7. https://doi.org/10.1245/ASO.2005.05.020.

Article  PubMed  Google Scholar 

Boers A, Arts HJ, Klip H, et al. Radical surgery in patients with residual disease after (chemo)radiation for cervical cancer. Int J Gynecol Cancer. 2014;24(7):1276–85. https://doi.org/10.1097/igc.0000000000000171.

Article  PubMed  Google Scholar 

Perez CA, Grigsby PW, Camel HM, Galakatos AE, Mutch D, Lockett MA. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 1995;31(4):703–16. https://doi.org/10.1016/0360-3016(94)00523-0.

Article  CAS  PubMed  Google Scholar 

Shim SH, Kim SN, Chae SH, Kim JE, Lee SJ. Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis. J Gynecol Oncol. 2018;29(2):e25. https://doi.org/10.3802/jgo.2018.29.e25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pervin S, et al. Adjuvant hysterectomy in patients with residual disease after radiation for locally advanced cervical cancer: a prospective longitudinal study. JGO. 2019;5:1–7. https://doi.org/10.1200/JGO.18.00157.

Article  PubMed  Google Scholar 

Morice P, Rouanet P, Rey A, et al. Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer. Oncologist. 2012;17(1):64–71. https://doi.org/10.1634/theoncologist.2011-0276.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lèguevaque P, Motton S, Delannes M, et al. Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer? Eur J Obstet Gynecol Reprod Biol. 2011;155(2):188–92. https://doi.org/10.1016/j.ejogrb.2010.11.016.

Article  PubMed  Google Scholar 

Yang J, Yang J, Cao D, Shen K, Ma J, Zhang F. Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery. J Gynecol Oncol. 2020;31(2): e16. https://doi.org/10.3802/jgo.2020.31.e16.

Article  PubMed  Google Scholar 

Truffa Kleine R, Sadalla J, Genta M, et al. (2018) Role of completion hysterectomy after concomitant chemoradiation in cervical cancer outcome. Int J Gynecol Cancer. 2019;29:A95–6.

Google Scholar